A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma.
Rep Pract Oncol Radiother
; 28(6): 809-822, 2023.
Article
em En
| MEDLINE
| ID: mdl-38515813
ABSTRACT
Background:
This article aimed to compile and summarize clinically relevant literature in radiation therapy, and to discuss the potential in radioresistant and radiosensitive head and neck cancer. StudyDesign:
Narrative review. Materials andmethods:
Google Scholar, PubMed and the Cochrane Library were retrieved using combined key words such as "radiotherapy" and "head and neck cancer". Search strings additionally queried were "radioresistant", "radiosensitive", "head and neck region", "squamous cell carcinoma", in combination with Boolean Operators 'AND' and 'OR'. Subsequently, the resulting publications were included for review of the full text.Results:
Radiotherapeutic response currently in clinical observation referred to HNSCC scoping were selected into this review. The compiled mechanisms were then detailed concerning on the clinical significance, biological characteristics, and molecular function.Conclusions:
Brachytherapy or/and external-beam radiotherapy are crucial for treating HNSCC, especially the early stage patients, but in patients with locally advanced tumors, their outcome with radiation therapy is poor due to obvious radioresistance. The curative effects mainly depend on the response of radiation therapy, so an updated review is needed to optimize further applications in HNSCC radiotherapy.
Texto completo:
1
Bases de dados:
MEDLINE
Idioma:
En
Revista:
Rep Pract Oncol Radiother
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
China